(Q57386663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Big risks in small groups: The difference between epidemiology and counselling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

J. M. Friedman

series ordinal

1

0 references

publication date

1 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

Birth Defects Research Part A: Clinical and Molecular Teratology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

720-724

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

Neurobehavioral teratology of isotretinoin

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Why animal studies are often poor predictors of human reactions to exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Thalidomide, a current teratogen in South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

A review of modern multiple hypothesis testing, with particular attention to the false discovery proportion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Chorionic villus sampling: a distinctive teratogenic effect on fingers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Antidepressant drugs during pregnancy and infant congenital heart defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Congenital Minamata disease: warnings from Japan's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

The challenge of subgroup analyses--reporting without distorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

An assessment of lithium using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents. IEHR Expert Scientific Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Update on new developments in the study of human teratogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Recognition of thalidomide defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Statistics in medicine--reporting of subgroup analyses in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.20606

21 January 2018

Identifiers

DOI

10.1002/BDRA.20606

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572407%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference